Tirabrutinib hydrochloride is a potent, highly selective, and irreversible oral BTK inhibitor. Tirabrutinib hydrochloride irreversibly covalently binds to Bruton tyrosine kinase (BTK) in B cells and exhibits potent in vitro cytotoxicity against many types of B cell malignancies, as well as in vivo antitumor activity in mouse models [1].
Molecular Weight:
490.94
Purity:
98.90%
CAS Number:
[1439901-97-9]
Formula:
C25H23ClN6O3
Target:
Apoptosis|||BTK
T12311
* VAT and and shipping costs not included. Errors and price changes excepted
